Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to evaluate candidate predictors of persistence on adalimumab (Imraldi®) participants diagnosed with immune-mediated inflammatory disease in Europe (EU). The se...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Biogen
NCT07047703 · Axial Spondyloarthritis (AxSpA)
NCT06083090 · Axial Spondyloarthritis (axSPA)
NCT06699238 · Axial Spondyloarthritis (AxSpA), Aerobic Exercise, and more
NCT03020992 · Axial Spondyloarthritis (axSpA), Anterior Uveitis (AU)
NCT02019602 · Axial Spondyloarthritis (AxSpA), Non-radiographic Evidence-AxSpA, and more
Research Site
Bruges
Research Site
Brussels
Research Site
Genk
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions